Women with polycystic ovarian syndrome undergoing conventional assisted reproduction techniques are at an increased risk of ovarian hyperstimulation. Polycystic ovarian syndrome is often associated with the retrieval of immature oocytes, poor fertilisation, and low pregnancy rates. These women might benefit from the earlier retrieval of oocytes followed by maturation of the oocytes in the laboratory (IVM) thus reducing the risk of the women experiencing ovarian hyperstimulation syndrome. Successful fertilisation, embryo development, and term pregnancies resulting from IVM oocytes have been reported, along with some concern regarding the safety of the method with respect to the health of the children and the rate of congenital anomalies.
The update of this review found no trials to help assess the risks and benefits of IVM in infertile women with polycystic ovarian syndrome as compared to conventional assisted reproduction technology techniques.
In vitro maturation in subfertile women with polycystic ovarian hyperstimulation syndrome who are undergoing assisted reproduction
Published Online:
May 11, 2011
Health topics:
More like this
- Interventions for 'poor responders' to controlled ovarian hyperstimulation (COH) in in-vitro fertilisation (IVF)
- Growth hormone in in-vitro fertilisation
- Gonadotrophin-releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles
- Soft versus firm catheters for intrauterine insemination
- Techniques for preparation prior to embryo transfer
